authors
- Garcia, AA
- Oza, AM
- Hirte, Holger
- Fleming, G
- Tsao-Wei, D
- Roman, L
- Swenson, S
- Gandara, D
- Scudder, S
- Morgan, R
Interim report of a phase II clinical trial of bevacizumab (Bev) and low dose metronomic oral cyclophosphamide (mCTX) in recurrent ovarian (OC) and primary peritoneal carcinoma: A California Cancer Consortium Trial.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2005
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal